KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Cash & Current Investments (2016 - 2026)

Emergent BioSolutions has reported Cash & Current Investments over the past 17 years, most recently at $161.5 million for Q1 2026.

  • For Q1 2026, Cash & Current Investments rose 5.69% year-over-year to $161.5 million; the TTM value through Mar 2026 reached $161.5 million, up 5.69%, while the annual FY2025 figure was $209.1 million, 98.01% up from the prior year.
  • Cash & Current Investments for Q1 2026 was $161.5 million at Emergent BioSolutions, down from $209.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $642.6 million in Q4 2022 and troughed at $71.0 million in Q2 2024.
  • A 5-year average of $226.6 million and a median of $161.5 million in 2026 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: crashed 82.62% in 2023 and later soared 281.69% in 2025.
  • Year by year, Cash & Current Investments stood at $642.6 million in 2022, then crashed by 82.62% to $111.7 million in 2023, then dropped by 5.46% to $105.6 million in 2024, then soared by 98.01% to $209.1 million in 2025, then dropped by 22.76% to $161.5 million in 2026.
  • Business Quant data shows Cash & Current Investments for EBS at $161.5 million in Q1 2026, $209.1 million in Q4 2025, and $249.2 million in Q3 2025.